MR 4.5 predicts survival of CML patients better than complete cytogenetic remission and is achieved faster by optimized high dose imatinib - results from the randomized CML-study IV
ONKOLOGIE(2013)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined